CVR 39733560Private limited company (ApS)Undervisning inden for sport og fritid (855100)BirkerødFounded 16 Jul 2018
CVR holds no employment figures for this company.
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about New Normal Labs ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexGross profit
-1.9K
DKK, annual report 2025
Result
-3.3K
DKK, annual report 2025
Equity
8.4K
DKK, annual report 2025
CVR registers no owner holding 5% or more.
Martin Kremmersince 16 Jul 2018
Equity of 8.4K DKK was below half the share capital of 40K DKK at 31 Dec 2025. Under the Companies Act (selskabsloven § 119) management must then account for the company's finances at a general meeting. Dandex estimate, computed 7 Nov 2026.
CVR registers no owner holding 5% or more.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
1 Danish company, which own 2 more one level down.
CVR 3656240410% to under 15% of capital and votes
CVR 38576496100% of capital and votes
CVR 39005166100% of capital and votes
Found by searching the CVR owner register (ejerregister) for New Normal Labs ApS as owner: Danish companies it holds 5% or more of, and their holdings one level down. Foreign holdings are not in CVR.
CVR 4050533425% to under 33.3% of capital and votes8 Jun 2021 to 26 Aug 2022
CVR records founders at incorporation. It does not record whether they are alive or still involved.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | -19 | 33 | -17 | Not reported | -2 |
| Operating profit | Not reported | +33 | -17 | -7 | -2 |
| Result for the year | -20 | +32 | -18 | -7 | -3 |
| Equity | 4 | 36 | 19 | 12 | 8 |
| Total assets | 64 | 65 | 260 | 257 | 254 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | -427.9% | n.m.note 1 | -153.1% | Not reportednote 2 | n.m.note 1 |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -22note 3 | -6note 3 | -22note 3 | -15note 3 | -5note 3 |
| ROIC (afkast af investeret kapital) | n.m.note 4 | Not reportednote 5 | -102.1%note 6 | n.m.note 4 | -1,272.5%note 6 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | -1note 3 | 15note 3 | 10note 3 | 31note 3 | 9note 3 |
DKK thousands. Annual reports via XBRL.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 6 Jul 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 5 Apr 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 30 Jun 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 7 Jul 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 3 Jul 2022
Each registered value from the day it took effect, newest first.
From CVR, read 7 Nov 2026. Text such as the signing rule and purpose is shown as registered.
2 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Virksomheden er omregistreret fra Iværksætterselskab til Anpartsselskab
Vedtægter ændret: 08.10.2021
Nyt navn: New Normal Labs ApS
Nye binavne: New Normal Coach ApS, New Normal Products ApS, New Normal Research ApS
Slettede binavne: New Normal Coach IVS, New Normal Products IVS, New Normal Research IVS
Kapitalforhøjelsen er besluttet den 08.10.2021.
kr. 39.999,00, indbetalt kontant, kurs 100,00.
Kapitalen udgør herefter kr. 40.000,00.
Binavne: New Normal Coach IVS, New Normal Products IVS, New Normal Research IVS.
Stiftelsesdato: 16.07.2018.
Seneste vedtægtsdato: 16.07.2018.
Kapital:
kr. 1,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 1,00 til kurs 100,00, fuldt indbetalt.
Stifter:
Martin Kremmer, den 16.07.2018.
Direktion:
Martin Kremmer (adm. dir), den 16.07.2018.
Virksomheden tegnes af en direktør alene.
Første regnskabsår:
16.07.2018 - 31.12.2019.
Regnskabsår:
01.01 - 31.12.
Formål:
Virksomhedens formål er at coache individer og teams opnå deres mål, igennem data-understøttede værktøjer til optimal ernærring, træning, mental optimering. Virksomheden har gennem udvidet adgang til et bredt internationalt Biohacking netværk, mulighed for at inddrage den seneste viden samt eksperter, til at understøtte alle facetter af rejsen imod en ny "norm" for individet eller teamet.
1 registered in CVR.
P-number 1023805878Vestre Teglværksvej 7, 3460 Birkerød
